Regulation of drug metabolism and toxicity by multiple factors of genetics, epigenetics, lncRNAs, gut microbiota, and diseases: a meeting report of the 21st International Symposium on Microsomes and Drug Oxidations (MDO)

[1]  B. Buckley,et al.  Restoration of enterohepatic bile acid pathways in pregnant mice following short term activation of Fxr by GW4064. , 2016, Toxicology and applied pharmacology.

[2]  M. Ingelman-Sundberg,et al.  Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and disease , 2016, Scientific Reports.

[3]  Peter J. Turnbaugh,et al.  The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism , 2016, Nature Reviews Microbiology.

[4]  Philip A. Ewels,et al.  Single base resolution analysis of 5-hydroxymethylcytosine in 188 human genes: implications for hepatic gene expression , 2016, Nucleic acids research.

[5]  A. Yu,et al.  MicroRNA Pharmacoepigenetics: Posttranscriptional Regulation Mechanisms behind Variable Drug Disposition and Strategy to Develop More Effective Therapy , 2016, Drug Metabolism and Disposition.

[6]  E. Schuetz,et al.  Interindividual Variability in Cytochrome P450–Mediated Drug Metabolism , 2016, Drug Metabolism and Disposition.

[7]  C. Klaassen,et al.  Regulation of Hepatic Drug-Metabolizing Enzymes in Germ-Free Mice by Conventionalization and Probiotics , 2016, Drug Metabolism and Disposition.

[8]  M. Huang,et al.  Regulation of drug-metabolizing enzymes by local and systemic liver injuries , 2016, Expert opinion on drug metabolism & toxicology.

[9]  Andreas Zell,et al.  Coordinating Role of RXRα in Downregulating Hepatic Detoxification during Inflammation Revealed by Fuzzy-Logic Modeling , 2016, PLoS Comput. Biol..

[10]  James Y. Zou.  Analysis of protein-coding genetic variation in 60,706 humans , 2015, Nature.

[11]  U. Hofmann,et al.  Heritability of metoprolol and torsemide pharmacokinetics , 2015, Clinical pharmacology and therapeutics.

[12]  C. Klaassen,et al.  Deciphering the Developmental Dynamics of the Mouse Liver Transcriptome , 2015, PloS one.

[13]  D. Waxman,et al.  Hepatic Long Intergenic Noncoding RNAs: High Promoter Conservation and Dynamic, Sex-Dependent Transcriptional Regulation by Growth Hormone , 2015, Molecular and Cellular Biology.

[14]  H. Swanson,et al.  Drug Metabolism by the Host and Gut Microbiota: A Partnership or Rivalry? , 2015, Drug Metabolism and Disposition.

[15]  E. Chan,et al.  Investigation of Host–Gut Microbiota Modulation of Therapeutic Outcome , 2015, Drug Metabolism and Disposition.

[16]  C. Klaassen,et al.  Developmental Regulation of Drug-Processing Genes in Livers of Germ-Free Mice. , 2015, Toxicological sciences : an official journal of the Society of Toxicology.

[17]  D. Waxman,et al.  Cross Talk Between GH-Regulated Transcription Factors HNF6 and CUX2 in Adult Mouse Liver. , 2015, Molecular endocrinology.

[18]  M. Huang,et al.  Estrogen sulfotransferase ablation sensitizes mice to sepsis , 2015, Nature Communications.

[19]  U. Hofmann,et al.  Inflammation-Associated MicroRNA-130b Down-Regulates Cytochrome P450 Activities and Directly Targets CYP2C9 , 2015, Drug Metabolism and Disposition.

[20]  M. Huang,et al.  Estrogen Sulfotransferase Is an Oxidative Stress-responsive Gene That Gender-specifically Affects Liver Ischemia/Reperfusion Injury* , 2015, The Journal of Biological Chemistry.

[21]  Xiaobo Zhong,et al.  Epigenetic regulation of drug metabolism and transport , 2015, Acta pharmaceutica Sinica. B.

[22]  Xi C. He,et al.  Developmental Programming of Long Non-Coding RNAs during Postnatal Liver Maturation in Mice , 2014, PloS one.

[23]  R Donald Harvey,et al.  Cancer, Inflammation, and Therapy: Effects on Cytochrome P450–Mediated Drug Metabolism and Implications for Novel Immunotherapeutic Agents , 2014, Clinical pharmacology and therapeutics.

[24]  M. Ingelman-Sundberg,et al.  Epigenetic mechanisms of importance for drug treatment. , 2014, Trends in pharmacological sciences.

[25]  M. Ingelman-Sundberg,et al.  Potential Role of Epigenetic Mechanisms in the Regulation of Drug Metabolism and Transport , 2013, Drug Metabolism and Disposition.

[26]  P. Turnbaugh,et al.  Predicting and Manipulating Cardiac Drug Inactivation by the Human Gut Bacterium Eggerthella lenta , 2013, Science.

[27]  M. Schwab,et al.  Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. , 2013, Pharmacology & therapeutics.

[28]  M. Redinbo,et al.  Multiple NSAID-induced hits injure the small intestine: underlying mechanisms and novel strategies. , 2013, Toxicological sciences : an official journal of the Society of Toxicology.

[29]  L. Aleksunes,et al.  Alteration of the Expression of Pesticide-Metabolizing Enzymes in Pregnant Mice: Potential Role in the Increased Vulnerability of the Developing Brain , 2013, Drug Metabolism and Disposition.

[30]  C. Gibson,et al.  Down-Regulation of Brush Border Efflux Transporter Expression in the Kidneys of Pregnant Mice , 2013, Drug Metabolism and Disposition.

[31]  A. Slitt,et al.  Pregnancy Represses Induction of Efflux Transporters in Livers of Type I Diabetic Mice , 2013, Pharmaceutical Research.

[32]  P. Thomas,et al.  Regulation of Hepatic Phase II Metabolism in Pregnant Mice , 2013, The Journal of Pharmacology and Experimental Therapeutics.

[33]  M Schwab,et al.  Genomics of ADME gene expression: mapping expression quantitative trait loci relevant for absorption, distribution, metabolism and excretion of drugs in human liver , 2011, The Pharmacogenomics Journal.

[34]  Lauren M Aleksunes,et al.  Repression of hepatobiliary transporters and differential regulation of classic and alternative bile acid pathways in mice during pregnancy. , 2012, Toxicological sciences : an official journal of the Society of Toxicology.

[35]  D. Waxman,et al.  Dynamic, Sex-Differential STAT5 and BCL6 Binding to Sex-Biased, Growth Hormone-Regulated Genes in Adult Mouse Liver , 2011, Molecular and Cellular Biology.

[36]  Matthew R. Redinbo,et al.  Alleviating Cancer Drug Toxicity by Inhibiting a Bacterial Enzyme , 2010, Science.

[37]  A. H. Tolson,et al.  Regulation of drug-metabolizing enzymes by xenobiotic receptors: PXR and CAR. , 2010, Advanced drug delivery reviews.

[38]  Ernest Fraenkel,et al.  Unbiased, Genome-Wide In Vivo Mapping of Transcriptional Regulatory Elements Reveals Sex Differences in Chromatin Structure Associated with Sex-Specific Liver Gene Expression , 2010, Molecular and Cellular Biology.

[39]  D. Waxman,et al.  Sex Differences in the Expression of Hepatic Drug Metabolizing Enzymes , 2009, Molecular Pharmacology.

[40]  C. Falany,et al.  TRICLOSAN AS A SUBSTRATE AND INHIBITOR OF 3′-PHOSPHOADENOSINE 5′-PHOSPHOSULFATE-SULFOTRANSFERASE AND UDP-GLUCURONOSYL TRANSFERASE IN HUMAN LIVER FRACTIONS , 2004, Drug Metabolism and Disposition.

[41]  W. Song.  Biochemistry and Reproductive Endocrinology of Estrogen Sulfotransferase , 2001, Annals of the New York Academy of Sciences.

[42]  M. Relling,et al.  Pharmacogenomics: translating functional genomics into rational therapeutics. , 1999, Science.

[43]  A. Fuller.  IS p-AMINOBENZENESULPHONAMIDE THE ACTIVE AGENT IN PRONTOSIL THERAPY ? , 1937 .